$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Therapeutic preparation for inhalation 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-038/28
  • C07K-014/62
출원번호 US-0665585 (2000-09-18)
발명자 / 주소
  • Backstrom, Kjell Goran Erik
  • Dahlback, Carl Magnus Olof
  • Edman, Peter
  • Johansson, Ann Charlotte Birgit
출원인 / 주소
  • AstraZeneca AB
대리인 / 주소
    Fish & Richardson P.C.
인용정보 피인용 횟수 : 2  인용 특허 : 59

초록

A therapeutic preparation for inhalation which comprises insulin and a substance which enhances the absorption of insulin in the lower respiratory tract, is provided in the form of a powder preparation suitable for inhalation.

대표청구항

A therapeutic preparation for inhalation which comprises insulin and a substance which enhances the absorption of insulin in the lower respiratory tract, is provided in the form of a powder preparation suitable for inhalation. reater than 25,000 comprising the steps of providing a substantially pure

이 특허에 인용된 특허 (59)

  1. Meezan Elias (Birmingham AL) Pillion Dennis J. (Birmingham AL), Absorption enhancers for drug administration.
  2. Alexander Jose (Lawrence KS) Fix Joseph A. (Lawrence KS) Repta A. J. (Lawrence KS), Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingua.
  3. Alexander Jose (Lawrence KS) Repta A. J. (Lawrence KS) Fix Joseph A. (Lawrence KS), Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingua.
  4. Ganderton David (Exeter GB2) Kassem Nuha M. (London GB2), Aerosol carriers.
  5. Ganderton David (Exeter GB2) Kassem Nuha M. (London GB2), Aerosol carriers.
  6. Stanley Theodore H. (Salt Lake City UT), Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues.
  7. Poynton Christopher H. (London TX GB2) Reading Christopher L. (Kingwood TX), Biological magnetic colloids.
  8. Aliverti Valerio (Varese ITX) Dorigotti Luciano (Milan ITX) Fonio Teodoro (Milan ITX) Pinza Mario (Milan ITX), Calcitonin gene related peptide.
  9. Wang Yu-chang J. (Los Altos CA) Lee William A. (Los Altos CA) Narog Blair (Palo Alto CA), Composition and method for administration of pharmaceutically active substances.
  10. Ecanow Bernard (Wilmette IL), Composition and method for introducing heme, hemoproteins, and/or heme-hemoprotein complexes into the body.
  11. Stanley Theodore H. (Salt Lake City UT) Hague Brian (West Valley City UT), Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments.
  12. Hodson Peter D. (Trowell GB2) Greenleaf David J. (Loughborough GB2), Deagglomerators for dry powder inhalers.
  13. Velasquez David J. (St. Paul) Hodson Peter D. (St. Paul) Calhoun Clyde D. (St. Paul MN), Device.
  14. Wetterlin Kjell I. L. (S Sandby SEX) Virtanen Risto (Nurmijrvi FIX) Andersson Jan A. R. (S Sandby SEX), Device in powder inhalators.
  15. Platz Robert M. ; Brewer Thomas K. ; Boardman Terence D., Dispersible macromolecule compositions and methods for their preparation and use.
  16. Wetterlin Kjell I. L. (S Sandby SEX), Dosage inhalator.
  17. Wetterlin Kjell I. L. (S Sandby SEX), Dosage inhalator.
  18. Carey Martin C. (Wellesley MA) Moses Alan C. (Waban MA) Flier Jeffrey S. (West Newton MA), Drug administration.
  19. Carey Martin C. (Wellesley MA) Moses Alan C. (Waban MA) Flier Jeffrey S. (West Newton MA), Drug administration.
  20. Carey, Martin C.; Moses, Alan C.; Flier, Jeffrey S., Drug administration.
  21. Ecanow Bernard (Wilmette IL), Drug delivery compositions and methods.
  22. Newhouse Michael T. (436 Queen Street South Hamilton ; Ontario CAX L8N 4A6) Baines W. Douglas (1675 Wedmore Way Mississauga ; Ontario CAX), Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow.
  23. Smith David K. (Loughborough GB2) Hodson Peter D. (Trowell GB2) Wass Anthony C. L. (Stamford GB2), Dry powder inhalers.
  24. Alexander, Jose; Fix, Joseph A., Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines.
  25. Virtanen Risto (Nurmijrvi FIX), Indicating means for a dosage dispensing device.
  26. Boardman Terence D. (Davenham GB2) Forrester Raymond B. (Sandbach GB2), Inhalation pharmaceuticals.
  27. Rubsamen Reid M. (Berkeley CA), Intrapulmonary delivery of hormones.
  28. Weiner Alan L. (Lawrenceville NJ), Lipid excipient for nasal delivery and topical application.
  29. Clark Andrew R. (Loughborough GB2) Hart John L. (Bramcote GB2), Medicament inhalation device and formulation.
  30. Zoltan Bart J. (Old Tappan NJ) Laube Beth L. (Baltimore MD) Adams ; III George K. (Baltimore MD), Medication delivery system phase one.
  31. Radhakrishnan Ramachandran (Fremont CA) Mihalko Paul J. (Fremont CA) Abra Robert M. (San Francisco CA), Method and apparatus for administering dehydrated liposomes by inhalation.
  32. Hora Maninder Singh ; Rubinfeld Joseph ; Stern Warren ; Wong Gregory J., Method and compositions for solubilization and stabilization of polypeptides, especially proteins.
  33. Patton John S. (San Carlos CA) Platz Robert M. (Half Moon Bay CA), Method and device for delivering aerosolized medicaments.
  34. Greenleaf David J. (Loughborough GB3) Purewal Tarlochan S. (Leamington Spa GB3) Jinks Philip A. (Mount Sorrel GB3), Method for preparing medicinal aerosol formulation containing coated medicament.
  35. Laube, Beth L.; Adams, III, G. Kenneth; Georgopoulos, Angeliki, Method of administering insulin.
  36. Rubsamen Reid M. (Berkeley CA), Method of administration of insulin.
  37. Patton John S. ; Foster Linda ; Platz Robert M., Methods and compositions for pulmonary delivery of insulin.
  38. Hansen Philip E. (Copenhagen DKX) Sorensen Anders R. (Herlev DKX), Nasal formulation and intranasal administration therewith.
  39. Fassberg Julianne (New York NY) Sequeira Joel A. (New York NY) Chaudry Imtiaz A. (North Caldwell NJ) Kopcha Michael (East Brunswick NJ), Non-chlorofluorocarbon aerosol formulations.
  40. Kagatani Seiya (Shizuoka JPX) Hasumi Shunji (Shizuoka JPX) Sonobe Takashi (Shizuoka JPX) Aruga Masayoshi (Shizuoka JPX), Pharmaceutical compositions comprising calcitonin and an absorption-promoting substance.
  41. Kagatani Seiya (Shizuoka JPX) Hasumi Shunji (Shizuoka JPX) Sonobe Takashi (Shizuoka JPX) Aruga Masayoshi (Shizuoka JPX), Pharmaceutical compositions for nasal administration comprising calcitonin and an absorption-promoting substance.
  42. Boyes Robert N. (St. Albans AL GB2) Tice Thomas R. (Birmingham AL) Gilley Richard M. (Birmingham AL) Pledger Kenneth L. (Huntsville AL), Pharmaceutical formulations comprising microcapsules.
  43. Suzuki Yoshiki (Tokyo JPX) Sekine Kunio (Tokyo JPX) Nagai Tsuneji (Tokyo JPX) Nambu Naoki (Kanagawa JPX) Nishimoto Yuji (Tokyo JPX), Powdery pharmaceutical composition for nasal administration.
  44. Miyauchi Yasuyo (Yokohama JPX), Preparation which promotes the absorption of peptides.
  45. Samejima Masayoshi (Mino) Noda Kazuo (Takarazuka) Kobayashi Masao (Kyoto) Osawa Takashi (Toyonaka JPX), Process for micronizing slightly-soluble drug.
  46. Platz Robert M. (Half Moon Bay CA) Ip Anna (Moorpark CA) Whitham Clyde L. (Montara CA), Process for preparing micronized polypeptide drugs.
  47. Platz Robert M. (Half Moon Bay CA) Winters Mark A. (Mountain View CA) Pitt Colin G. (Thousand Oaks CA), Pulmonary administration of granulocyte colony stimulating factor.
  48. Benson Bradley J. (170 Cresta Vista Dr. San Francisco CA 94127) Wright JoRae (170 Cresta Vista Dr. San Francisco CA 94127), Pulmonary administration of pharmaceutically active substances.
  49. Patton John S., Pulmonary delivery of active fragments of parathyroid hormone.
  50. Patton John S. (San Carlos CA), Pulmonary delivery of active fragments of parathyroid hormone.
  51. Wong Jeffrey T.-F. (Hong Kong HKX) Tam Michael S.-C. (Shatin HKX), Pulmonary drug delivery system.
  52. Feldstein Robert (Pelham NY) Glass John (Shoreham NY) Steiner Solomon S. (Mt. Kisco NY), Self assembling diketopiperazine drug delivery system.
  53. Illum Lisbeth,GB2, Small particle compositions for intranasal drug delivery.
  54. Friedman Doron (Carmei Yosef ILX) Schwarz Joseph (Rehovot ILX) Amselem Shimon (Rehovot ILX), Submicron emulsions for delivery of peptides.
  55. Bckstrm Kjell G. E. (Lund SEX) Dahlbck Carl M. O. (Lund SEX) Edman Peter (Bjrred SEX) Johansson Ann C. B. (Lund SEX), Systemic administration of a therapeutic preparation.
  56. Bckstrm Kjell G. E. (Lund SEX) Dahlbck Carl M. O. (Lund SEX) Edman Peter (Bjrred SEX) Johansson Ann C. B. (Lund SEX), Therapeutic preparation for inhalation.
  57. Longenecker John P. (Mountain View CA) Ennis Richard (Fremont CA) Baldwin Patricia A. (Hayward CA) Lee William A. (Los Altos CA), Transmembrane formulations for drug administration.
  58. Igari Yasutaka (Kobe JPX) Yamada Minoru (Kawanishi JPX) Taketomi Shigehisa (Ikeda JPX), Transmucosal therapeutic composition.
  59. Schultz Robert K. (Shoreview MN) Quessy Stephen N. (St. Paul MN), Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations.

이 특허를 인용한 특허 (2)

  1. Chandrasekaran, Aarthi; Sengupta, Shiladitya; Berry, David A.; Holley, Kristine; Zhao, Ganlin; Sasisekharan, Ram, Methods and compositions related to the modulation of intercellular junctions.
  2. Opawale, Foyeke; Soltero, Richard, Micro-particle fatty acid salt solid dosage formulations for therapeutic agents.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로